Mentioned
GlaxoSmithKline
GSK.L
-53.9190 (-3.57%)
S
1457.3108
B
1462.1900
GlaxoSmithKline
GSK.L
-53.9190 (-3.57%)
S
1457.3108
B
1462.1900
NASDAQ100 Index (Non Expiry)
NSDQ100
-31.90 (-0.16%)
S
20011.40
B
20014.40
UK100 Index (Non Expiry)
UK100
56.26 (0.68%)
S
8312.25
B
8317.75
Vanguard FTSE Emerging Markets
VWO
1.21 (2.53%)
S
48.96
B
49.13
GlaxoSmithKline plc ADR
GSK
-2.06 (-5.04%)
S
38.75
B
38.88
GlaxoSmithKline
GSK.L
-53.9190 (-3.57%)
S
1457.3108
B
1462.1900
J3mbo_Dividends
United Arab Emirates
about a month ago
$GSK.L (GlaxoSmithKline) on the rise today, bought in at fair value and given their robust and diverse range of products, we may see some more growth, read my post on $GSK.L to learn more! $NSDQ100 $UK100 $VWO $GSK (GlaxoSmithKline plc ADR) $GSK.L www.etoro.com/markets/gsk.l
Like CommentShare
7 Mentioned Show all
GlaxoSmithKline
GSK.L
GlaxoSmithKline
GlaxoSmithKline
GSK.L
GlaxoSmithKline
NASDAQ100 Index (Non Expiry)
NSDQ100
UK100 Index (Non Expiry)
UK100
Vanguard FTSE Emerging Markets
VWO
Vanguard FTSE Emerging Markets
GlaxoSmithKline plc ADR
GSK
GlaxoSmithKline plc ADR
GlaxoSmithKline
GSK.L
GlaxoSmithKline
null
.